NYSE: ALUR

US-based Allurion’s (NYSE: ALUR) weight-loss intragastric balloon has been first applied in Shanghai Ruijin Hospital’s Hainan subsidiary, offering a non-invasive weight loss solution for obese patients with a body mass index (BMI) greater than 27. This innovative device provides an alternative approach to weight management in a hospital setting. Clinically…